Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases ; volume:19 ; number:1 ; day:21 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
Orphanet journal of rare diseases ; 19, Heft 1 (21.5.2024), 1-12, 12.2024
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-024-03190-1
- URN
-
urn:nbn:de:101:1-2407310914477.121823886108
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hwang, Austin
- Kwon, Andie
- Miller, Corinne H.
- Reimer-Taschenbrecker, Antonia
- Paller, Amy S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy
Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases
STAT3 targeting in dystrophic epidermolysis bullosa
Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study
A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families
Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy
Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases
STAT3 targeting in dystrophic epidermolysis bullosa
Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study
A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families
Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy
Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases
STAT3 targeting in dystrophic epidermolysis bullosa
Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study
A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families
Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa